Comparison of Various Prosthetic Foot-Ankle Mechanisms

August 18, 2026 updated by: Massachusetts Institute of Technology
In summary, subjects will be asked to wear a number of sensors and use different ankle-foot prostheses in place of their customary prosthesis. Data will be collected from the wearable sensors, VICON motion capture system, video cameras, and force sensors in the ground as they walk on level-ground, on a treadmill, and on stairs. The controller of any powered prosthesis will be electronically adjusted between trials or while the subject walks to determine how their gait changes in response to these changes. Trials will also be conducted with a standard passive prosthesis that would be prescribed for a person of similar height and weight.

Study Overview

Detailed Description

Subject Selection and Consent:

Subjects will be selected based on the following priority. Subjects who have previously participated in similar studies with the Biomechatronics lab and who have already been screened for health and mobility level will be contacted first. If additional subjects are needed, a recruitment flyer and screening questionnaire will be sent to potential candidates. Copies of both the flyer and questionnaire are included in the attachments section. Prior to the experimental sessions, subjects will be asked to read and sign a informed consent form and will explain the project to them and answer any questions that they may have. They will also be given time to become familiar with the equipment being used before beginning any trials. If needed, subjects will be aligned and fitted by a professional prosthetist at A Step Ahead Prosthetics in Burlington, MA. No personnel at A Step Ahead Prosthetics will conduct research or have any vested interest in research outcomes or publication.

Attire:

Subjects will be asked to wear tight-fitting clothes, such as a skin-tight shirt, running shorts and low-profile shoes. If this is not possible, clothes will be provided according to subject needs. The investigators will provide and may require subjects to wear a skin-tight Velcro outfit that allows us to place reflective balls for video camera capture.

Location(s) and Timeline:

Experimental sessions will be conducted in the MIT Biomechatronics Laboratory (E14-274), 75 Amherst St., Cambridge, MA 02139 and the basement connecting MIT Building 66, 68, and E19 (31 Ames St., Cambridge, MA 02139). The basement is a publicly accessible area, and visible signage will be posted to alert passerby. Any alignment and fitting of prosthetic devices will take place at either the aforementioned location or at A Step Ahead Prosthetics, 21 A. St., Burlington, MA 01803 by a trained prosthetist.

Total study duration is expected to be 8 hours per subject, likely over two 4-hour sessions. These sessions can be completed either in a single day or over two days.

Powered Prosthesis:

Subjects will be given three or four computer-controlled quasi-passive (QP) ankle-foot prostheses to attach in place of their customary prosthesis during a session, depending on the arm. These include the Blatchford Elan, Ossur Proprio, a variable-stiffness prosthesis (VSA), and a variable-angle prosthesis (VAA). These QP prostheses have the capability of providing active assistance or changing mechanical properties during walking. Controls will be adjusted either through a wireless link or hardwire connection depending on the device. Subjects will be given as much time as necessary to practice using the prostheses before the experiments begin.

Passive Prosthesis:

Subjects will be given 1-3 passive prostheses to attach in place of their customary prosthesis during a session. These include the Ossur Pro-Flex XC and a passive sliding-beam prosthesis based on the Variable Stiffness prosthesis above with the electronics and actuator removed. In the first arm, a passive prosthesis that can change ankle equilibrium angle manually will be used. Subjects will be given as much time as necessary to practice using the prosthesis before the experiments begin.

Data Collection:

Data collection is expected to take place in two segments. In the first segment, each subject will walk on a treadmill at three speeds between 0.5-1.5m/s (slow to fast walking), chosen based on their comfort. At each speed, all five prostheses will be tested, randomly selected, for 2mins each. Motion will be captured with a VICON motion capture system, and ground reaction forces will be measured using a Bertec force-sensitive treadmill. For each speed, once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis performed at heel strike (early stance), roll over (mid stance), and powered plantar flexion (late stance). In addition, each subject will be asked how each prosthesis generally performed, and their personal preference. This testing will occur across the three walking speeds, resulting in three completed questionnaires.

In addition, subjects will walk in a figure-8 pattern at a preferred gait speed around two cones placed on the level-ground walking surface and separated by up to 30 feet. Handrails and a harness will be available to the subject as needed. Subjects will perform the walking figure-8 for a minimum of 5 times for each randomly-selected prosthesis. Once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis generally performed, and their personal preference.

Each subject will ascend and descend stairs and a ramp inclined between 4°-8° from horizontal at their preferred speed, in a randomly selected order. This incline is akin to between an ADA-compliant wheelchair ramp and a moderately inclined hill. Motion will be captured with a VICON motion capture system, and ground reaction forces will be measured using a Bertec force-sensitive treadmill for slope ambulation, and a force-sensitive staircase for stair ambulation. All five prostheses will be tested, randomly selected. Subjects will perform each of stair ascent and stair descent for a minimum of 5 times per prosthesis. For slopes and stairs, subjects will be asked to test different stiffnesses and angles and pick a preferred setting for the VSA and VAA, respectively. Data will be collected for a total of 2mins for slope ascent and 2mins for slope descent with each prosthesis. If necessary, subjects will test up to 5 ankles on an ADA-compliant over-ground ramp for additional slope ascent and slope descent evaluation. This will provide additional evaluation of differences between treadmill and over-ground slope walking for both subject and researcher. Subjects will walk up and down the ramp a minimum of 5 times per prosthesis. Handrails are available along the entire ramp, and a researcher will be beside the subject for assistance. For each slope and stair ascent/descent, once all prostheses have been tested, each subject will be given a questionnaire to ascertain how each prosthesis generally performed, and their personal preference. This testing will occur across the slope terrain types, as well as after the stair ascent/descent trial, resulting in three completed questionnaires for each subject. If time allows, subjects may also be asked to test test up to 5 ankles a 30 ft. over-ground course consisting of level-ground, stairs, and slopes in order to evaluate transitions between terrains. Subjects will perform the course a minimum of 3 times. This will not be evaluated via questionnaire and is meant to provide information to the researcher on future prosthetic design. Handrails are available for all elements except an adjustable ramp, for which a researcher will be beside the subject for assistance.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Burlington, Massachusetts, United States, 01803
        • A Step Ahead Prosthetics
      • Cambridge, Massachusetts, United States, 02139
        • MIT Media Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Person with unilateral transtibial amputation
  • K3 or K4 Medicare mobility rating
  • Ages 18-65

Exclusion Criteria:

  • Below K3 Medicare mobility rating
  • Outside of age range (liability and safety reasons)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Evaluation of first generation prototype prostheses
Clinical trial to evaluate efficacy of first generation of MIT prototype prosthetic ankle-foot devices on people with unilateral transtibial amputation over different walking speeds and terrains.
Proprietary fixed-stiffness passive foot-ankle prosthesis.
Other Names:
  • SB
Commercially-available electronically-controlled prosthesis that can vary its effective dampening.
Other Names:
  • EL
  • Elan
Proprietary electronically-controlled prosthesis that can vary its effective stiffness.
Other Names:
  • VS
  • VSA
Proprietary manually-controlled prosthesis that can vary its effective ankle equilibrium angle.
Other Names:
  • VA
  • VAA
Commercially-available passive fixed-stiffness foot-ankle prosthesis by Ossur.
Other Names:
  • PF
  • Pro-Flex XC
  • XC
Experimental: Evaluation of second generation of prototype prostheses
Clinical trial to evaluate efficacy of second generation of MIT prototype prosthetic ankle-foot devices on people with unilateral transtibial amputation over different walking speeds and terrains.
Commercially-available electronically-controlled prosthesis that can vary its effective dampening.
Other Names:
  • EL
  • Elan
Commercially-available passive fixed-stiffness foot-ankle prosthesis by Ossur.
Other Names:
  • PF
  • Pro-Flex XC
  • XC
Commercially available variable ankle angle prosthesis by Ossur.
Other Names:
  • PP
  • Proprio
Second generation a proprietary electronically-controlled prosthesis that can vary its effective stiffness.
Other Names:
  • VS
  • VSA
  • Folia
Second generation prototype prosthesis that can vary its effective ankle equilibrium angle.
Other Names:
  • VA
  • VAA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
User device preference for level-ground walking
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Determine which device the users prefer for level-ground walking by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)
User device preference for stair ascent & descent
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Determine which device the users prefer for stair ascent & descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)
User device preference for sloped ground ascent & descent
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Determine which device the users prefer for 8-degree sloped ground ascent & descent by gauging user feedback through an evaluation questionnaire. Evaluation units will be a sliding scale ranging from "Very unfavorable" to "Very favorable" with neutral in the middle. Subjects will be asked to rank the 5 interventions from best to worst for the specific task.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of device on level-ground walking gait
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Evaluate the effect of the device on level-ground walking gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Effect of device on stair ascent & descent gait
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Evaluate the effect of the device on stair ascent and descent gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Effect of device on sloped ground walking gait
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Evaluate the effect of the device on sloped ground walking gait patterns. Gait will be measured with a VICON motion capture system. Unit of measure is gait symmetry.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Effect of device on ground reaction force during ambulation
Time Frame: From enrollment to the end of trial (2 sessions, 8 hours total per patient)
Evaluate the effect of the device on ground reaction forces during ambulation. Ground reaction forces will be measured with Bertec force plates. Unit of measure is ground reaction force in Newtons.
From enrollment to the end of trial (2 sessions, 8 hours total per patient)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 28, 2023

Primary Completion (Actual)

April 1, 2026

Study Completion (Actual)

April 1, 2026

Study Registration Dates

First Submitted

July 11, 2023

First Submitted That Met QC Criteria

July 19, 2023

First Posted (Actual)

July 28, 2023

Study Record Updates

Last Update Posted (Actual)

August 20, 2026

Last Update Submitted That Met QC Criteria

August 18, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2306001029

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe